After spending the past four months as interim CEO of WindMIL Therapeutics, former Bristol-Myers Squibb executive Donald J. Hayden Jr. has accepted the position on a permanent basis. Hayden has spent the past two-plus years as chairman of the immunotherapy company and he will continue on that role. He will split his time between WindMIL’s Philadelphia office, where the company’s clinical, business operations and finance functions are located, and Baltimore, where the company’s research and…
from https://www.bizjournals.com/baltimore/news/2019/04/25/windmil-therapeutics-bristol-myers-squibb-ceo.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/184440933692
No comments:
Post a Comment